More articles from CCR Drug Updates

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y. Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie E. Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong, Chao Liu, Christopher M. Sheth, Steven Bowen, Kirsten B. Goldberg, Ann T. Farrell, Gideon M. Blumenthal, Richard Pazdur

Clinical Cancer Research Sep 2019, DOI: 10.1158/1078-0432.CCR-19-2329
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast Cancer
Suparna Wedam, Lola Fashoyin-Aje, Erik Bloomquist, Shenghui Tang, Rajeshwari Sridhara, Kirsten B. Goldberg, Marc R. Theoret, Laleh Amiri-Kordestani, Richard Pazdur, Julia A Beaver

Clinical Cancer Research Jan 2019, clincanres.2580.2019; DOI: 10.1158/1078-0432.CCR-19-2580
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia
Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L. Del Valle, Donna Przepiorka, Yuan-Li Shen, Christopher M. Sheth, Chao Liu, Ruby Leong, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur

Clinical Cancer Research Oct 2019, 25 (20) 6021-6025; DOI: 10.1158/1078-0432.CCR-19-0365
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults
Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L. Manning, Xu Michael Di, Donna Przepiorka, Frances Namuswe, Albert Deisseroth, Kirsten B. Goldberg, Gideon M. Blumenthal, Richard Pazdur

Clinical Cancer Research Aug 2019, DOI: 10.1158/1078-0432.CCR-19-1255
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome
Yvette L. Kasamon, Haiyan Chen, R. Angelo de Claro, Lei Nie, Jingjing Ye, Gideon M. Blumenthal, Ann T. Farrell, Richard Pazdur

Clinical Cancer Research Jul 2019, DOI: 10.1158/1078-0432.CCR-19-2030
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
Leigh Marcus, Steven J. Lemery, Patricia Keegan, Richard Pazdur

Clinical Cancer Research Jul 2019, 25 (13) 3753-3758; DOI: 10.1158/1078-0432.CCR-18-4070
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation
Kelly J. Norsworthy, Lola Luo, Vicky Hsu, Ramadevi Gudi, Sarah E. Dorff, Donna Przepiorka, Albert Deisseroth, Yuan-Li Shen, Christopher M. Sheth, Rosane Charlab, Gene M. Williams, Kirsten B. Goldberg, Ann T. Farrell, Richard Pazdur

Clinical Cancer Research Jun 2019, 25 (11) 3205-3209; DOI: 10.1158/1078-0432.CCR-18-3749
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast Cancer
Lynn J. Howie, Nancy S. Scher, Laleh Amiri-Kordestani, Lijun Zhang, Bellinda L. King-Kallimanis, Yasmin Choudhry, Jason Schroeder, Kirsten B. Goldberg, Paul G. Kluetz, Amna Ibrahim, Rajeshwari Sridhara, Gideon M. Blumenthal, Richard Pazdur, Julia A. Beaver

Clinical Cancer Research May 2019, 25 (10) 2949-2955; DOI: 10.1158/1078-0432.CCR-18-3003
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss, Xin Gao, Liang Li, Michael L. Manning, Paresma Patel, Wentao Fu, Kumar G. Janoria, Gerlie Gieser, David A. Bateman, Donna Przepiorka, Yuan Li Shen, Stacy S. Shord, Christopher M. Sheth, Anamitro Banerjee, Jiang Liu, Kirsten B. Goldberg, Ann T. Farrell, Gideon M. Blumenthal, Richard Pazdur

Clinical Cancer Research May 2019, 25 (9) 2685-2690; DOI: 10.1158/1078-0432.CCR-18-2990
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Najat Bouchkouj, Yvette L. Kasamon, R. Angelo de Claro, Bindu George, Xue Lin, Shiowjen Lee, Gideon M. Blumenthal, Wilson Bryan, Amy E. McKee, Richard Pazdur

Clinical Cancer Research Mar 2019, 25 (6) 1702-1708; DOI: 10.1158/1078-0432.CCR-18-2743

Main menu

User menu

Search

More articles from CCR Drug Updates

Pages

Articles

Info for

About Clinical Cancer Research